Jessica Suero
Payments from drug & device makers
Across 232 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Collegium Pharmaceutical, Inc.$663
- Forte Bio-pharma LLC$634
- Scilex Pharmaceuticals Inc.$527
- Nevro Corp.$402
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$240
- plus $937 from 15 others
What the payments were for
- Travel & lodging$3578%
- Food & beverage$4,01291%
- Education$541%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 30 | $1,019 |
| Collegium Pharmaceutical, Inc. | 51 | $663 |
| Forte Bio-pharma LLC | 31 | $634 |
| Scilex Pharmaceuticals Inc. | 23 | $527 |
| Nevro Corp. | 11 | $402 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $240 |
| Biodelivery Sciences International, Inc. | 33 | $198 |
| AbbVie | 9 | $159 |
| Pfizer | 8 | $141 |
| Boston Scientific | 2 | $78 |
| Amgen | 4 | $74 |
| Azurity Pharmaceuticals, Inc. | 4 | $67 |
| Saluda Medical Americas, Inc. | 3 | $66 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 1 | $25 |
| Averitas Pharma Inc. | 1 | $23 |
| Abbott | 1 | $17 |
| Vertex | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Almatica Pharma LLC | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$447
- ELYXYB - CELECOXIB$176
- Senza$128
- Omnia$125
- Nalocet$118
- Prolate$118
How this compares
$4,422 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Epolamine | 21 | $33,488 |
| Diclofenac Sodium | 27 | $23,852 |
| Lidocaine | 59 | $13,246 |
| Calcipotriene | 16 | $7,576 |
| Cyclobenzaprine Hcl | 99 | $4,298 |
| Gabapentin | 181 | $2,227 |
| Methocarbamol | 95 | $900 |
| Celecoxib | 32 | $668 |
| Methylprednisolone | 84 | $584 |
| Tizanidine Hcl | 55 | $359 |
| Ketorolac Tromethamine | 19 | $268 |
| Baclofen | 16 | $232 |
| Meloxicam | 42 | $137 |
Paid to pharmacies, not to this prescriber.
Other family in Plano
- Kori NelsonPlano$148K
- Zaineb ShamsPlano$64K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.